BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29036977)

  • 1. [Safety and feasibility of sheathless transfemoral aortic valve implantation].
    Pei HJ; Teng SY; Luo T; Wu YJ; Yang YJ; Qiao SB; Xu B; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):782-785. PubMed ID: 29036977
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Taramasso M; Denegri A; Kuwata S; Rickli H; Haager PK; Sütsch G; Rodriguez Cetina Biefer H; Kottwitz J; Nietlispach F; Maisano F
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):533-539. PubMed ID: 28500739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
    Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
    J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter aortic valve replacement using the iSleeve expandable sheath in small femoral arteries.
    Glaser N; O'Sullivan CJ; Saleh N; Verouhis D; Settergren M; Linder R; Rück A
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34642241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and efficacy of transcatheter aortic valve replacement through transcarotid approach for patients with severe aortic valve stenosis].
    Pan WZ; Zhou DX; Zhang XC; Zhang L; Wei L; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):198-202. PubMed ID: 29562424
    [No Abstract]   [Full Text] [Related]  

  • 6. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
    Abu Saleh WK; Tang GH; Ahmad H; Cohen M; Undemir C; Lansman SL; Reyes M; Barker CM; Kleiman NS; Reardon MJ; Ramlawi B
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):135-43. PubMed ID: 26603266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters.
    Geis NA; Chorianopoulos E; Kallenbach K; André F; Pleger ST; Karck M; Katus HA; Bekeredjian R
    Clin Res Cardiol; 2014 Oct; 103(10):775-80. PubMed ID: 24748131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
    Sedaghat A; Sinning JM; Werner N
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E613-6. PubMed ID: 23460472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of temporary distal aortic occlusion to facilitate TAVR large-bore arterial closure.
    Bowers B; Anderson J; Brown D
    J Invasive Cardiol; 2014 Aug; 26(8):394-6. PubMed ID: 25091100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Stent Graft Implantation for Treatment of Access Site Bleeding After Transfemoral Transcatheter Aortic Valve Replacement.
    Segal A; Flugelman MY; Khader N; Rubinshtein R; Lavi I; Karmeli R; Jubran A; Shiran A; Jaffe R
    Am J Cardiol; 2017 Aug; 120(3):456-460. PubMed ID: 28583682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suprasternal Transcatheter Aortic Valve Replacement in Patients With Marginal Femoral Access.
    Kiser AC; Caranasos TG; Peterson MD; Holzhey DM; Kiefer P; Nifong LW; Borger MA
    Innovations (Phila); 2018; 13(1):1-4. PubMed ID: 29462049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of transcatheter aortic valve replacement using Venus-A valve for treating patients with severe aortic stenosis].
    Song GY; Wang MY; Wang Y; Liu XB; Feng Y; Kong XQ; Wu YJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):843-847. PubMed ID: 29081172
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.
    Steinvil A; Bernardo N; Rogers T; Koifman E; Buchanan K; Alraies MC; Shults C; Torguson R; Okubagzi PG; Pichard AD; Satler LF; Ben-Dor I; Waksman R
    Cardiovasc Revasc Med; 2017 Mar; 18(2):128-132. PubMed ID: 27865711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis.
    Eltchaninoff H; Kerkeni M; Zajarias A; Tron C; Godin M; Sanchez Giron C; Baala B; Cribier A
    EuroIntervention; 2009 Sep; 5(4):438-42. PubMed ID: 19755330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.